Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Roche Honors Next Generation of Chemists

May 24, 2011 8:09 am | News | Comments

Roche honored 12 doctoral students and two professors with the company’s Excellence in Chemistry Award for research accomplishments in the field of organic chemistry.


BioCritica Inc. Formed

May 24, 2011 8:04 am | News | Comments

Eli Lilly and Company has signed agreements with Care Capital and NovaQuest Capital to establish BioCritica Inc., a   privately-held biotechnology company.


GenKyoTex Raises Funds to Develop NOX Enzyme Inhibitors

May 24, 2011 8:04 am | News | Comments

GenKyoTex has raised CHF18 million ($20.4 million), which will be used for the clinical development of the lead compound GKT137831 for the treatment of diabetic nephropathy.


New Bone Production

May 24, 2011 7:41 am | News | Comments

A study by researchers at Children’s Hospital Boston and collaborators has provided new insight into how bone cells produce new bone in response to mechanical stresses, such as exercise.


Natural Product Has Potent Pain-Killing Properties

May 24, 2011 7:29 am | News | Comments

Scientists from the Scripps Research Institute have synthesized of a rare natural product isolated from the bark of a plant widely employed in traditional medicine. This advance may provide the scientific foundation to develop an effective alternative to commonly prescribed narcotic pain treatments.


Stem Cells Made into Astrocytes

May 24, 2011 7:24 am | News | Comments

A group led by University of Wisconsin-Madison stem cell researcher Su-Chun Zhang has; directed embryonic and induced human stem cells to become astrocytes in the lab dish.


Par Buying Edict for $37.6M

May 23, 2011 11:46 am | News | Comments

Generic drug developer Par Pharmaceutical Companies Inc. said it will buy privately held Edict Pharmaceuticals for up to $37.6 million in cash. Edict, based in Chennai, India, makes solid, oral dose generic drugs.


Almac Opens North American HQ

May 23, 2011 11:41 am | News | Comments

The Almac Group has officially opened its North American Headquarters in Souderton, PA. The $120 million, 240,000-square-foot building houses more than 800 employees and has already brought approximately 300 new hires to the greater Philadelphia region.


Strainer Bags

May 23, 2011 11:34 am | Product Releases | Comments

Seward Limited has further enhanced the application range of its Strainer bags to include sterile processing of tissue samples for primary cell preparation. The bags are Gamma irradiated sterile and available in a range of sizes.


ICP-OE Spectrometers

May 23, 2011 11:28 am | Product Releases | Comments

PerkinElmer Inc. announced the launch of its Optima 8x00 series of Inductively Coupled Plasma Optical Emission Spectrometers. The Optima 8x00 ICP-OES platform offers improved performance and reduced operating costs.


Anavex Stepping Up Dosage in Phase 1 Trial

May 23, 2011 11:23 am | News | Comments

Anavex Life Sciences Corp. announced that the Safety Review Committee for ANAVEX 2-73, its lead candidate for Alzheimer’s disease, unanimously approved skipping the 5 mg dose and moving directly to the 10 mg dose step.


Abbott Applies for Cancer Test Approval

May 23, 2011 11:14 am | News | Comments

Abbott announced it filed premarket approval applications to the U.S. Food and Drug Administration for a new molecular diagnostic test designed to detect abnormal gene rearrangements in non-small-cell lung cancer tumors.


J & J Buying J B Chemicals for $260M

May 23, 2011 10:48 am | News | Comments

Johnson & Johnson said that its Cilag GmbH unit will expand its business in Russia by buying the over-the-counter brands of J B Chemicals & Pharmaceuticals Ltd. for $260 million in cash.


Lilly Spinout to Sell Xigris

May 23, 2011 10:45 am | News | Comments

Drugmaker Eli Lilly and Co. said it will work with some private investors to create a privately held biotechnology company to sell the severe sepsis treatment Xigris and possibly develop other drugs.


FDA Clears Incivek for Hepatitis

May 23, 2011 10:43 am | News | Comments

The Food and Drug Administration approved Vertex Pharmaceuticals Inc.'s hepatitis C drug Incivek Monday, making it the second new treatment to be approved in the last two weeks.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.